ZUDDAS, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 107.351
NA - Nord America 10.878
AS - Asia 4.874
SA - Sud America 718
AF - Africa 107
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 4
Totale 123.972
Nazione #
IT - Italia 103.086
US - Stati Uniti d'America 10.681
SG - Singapore 1.998
CN - Cina 1.561
NL - Olanda 1.169
UA - Ucraina 753
BR - Brasile 568
SE - Svezia 554
VN - Vietnam 446
FR - Francia 419
GB - Regno Unito 380
DE - Germania 359
FI - Finlandia 324
HK - Hong Kong 234
IN - India 133
BD - Bangladesh 102
CA - Canada 102
KR - Corea 79
RU - Federazione Russa 59
TR - Turchia 45
AR - Argentina 43
ZA - Sudafrica 41
MX - Messico 40
AU - Australia 39
IQ - Iraq 39
AT - Austria 31
ES - Italia 31
PL - Polonia 27
CO - Colombia 26
PK - Pakistan 26
CH - Svizzera 24
SA - Arabia Saudita 24
EC - Ecuador 23
ID - Indonesia 23
JP - Giappone 20
VE - Venezuela 20
PH - Filippine 19
AE - Emirati Arabi Uniti 17
BE - Belgio 17
MA - Marocco 17
IL - Israele 15
CL - Cile 14
MY - Malesia 14
UZ - Uzbekistan 14
CR - Costa Rica 13
DK - Danimarca 13
IE - Irlanda 12
IR - Iran 12
JM - Giamaica 11
JO - Giordania 11
NO - Norvegia 11
RO - Romania 11
BO - Bolivia 10
GR - Grecia 10
ET - Etiopia 9
LT - Lituania 9
EG - Egitto 8
HN - Honduras 8
AL - Albania 7
DO - Repubblica Dominicana 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
KE - Kenya 6
PS - Palestinian Territory 6
PT - Portogallo 6
PY - Paraguay 6
BA - Bosnia-Erzegovina 5
KZ - Kazakistan 5
TW - Taiwan 5
AZ - Azerbaigian 4
GT - Guatemala 4
MD - Moldavia 4
NP - Nepal 4
PE - Perù 4
RS - Serbia 4
TH - Thailandia 4
DZ - Algeria 3
EE - Estonia 3
EU - Europa 3
MU - Mauritius 3
SN - Senegal 3
UY - Uruguay 3
BY - Bielorussia 2
GN - Guinea 2
KN - Saint Kitts e Nevis 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
SM - San Marino 2
TT - Trinidad e Tobago 2
AO - Angola 1
BG - Bulgaria 1
Totale 123.950
Città #
Cagliari 94.926
Uta 5.293
Amsterdam 1.079
Singapore 1.028
Fairfield 921
Ashburn 873
Woodbridge 846
San Jose 597
Chandler 596
Houston 579
Boardman 573
Ann Arbor 444
Dallas 438
Jacksonville 393
Wilmington 385
Seattle 361
Nyköping 340
Beijing 293
Cambridge 293
Milan 256
Rome 249
Council Bluffs 200
Helsinki 198
Hong Kong 197
Los Angeles 185
Boston 156
Hefei 147
Lauterbourg 132
Ho Chi Minh City 127
Nanjing 126
The Dalles 122
Santa Clara 116
New York 115
Dearborn 114
Buffalo 84
Hanoi 82
Dong Ket 80
Shanghai 73
San Diego 66
Seoul 64
Redwood City 54
Padova 49
Shenyang 48
São Paulo 47
Guangzhou 46
Charleston 44
Frankfurt am Main 44
Nanchang 38
Turin 38
Bari 37
Changsha 36
Verona 36
Toronto 35
Washington 34
Nuremberg 33
Palermo 33
Chicago 32
Orem 32
London 31
Atlanta 30
Florence 29
Naples 29
Sassari 29
Norwalk 28
Hebei 27
Bologna 26
Jiaxing 26
Redondo Beach 26
Brooklyn 25
San Francisco 25
Tianjin 25
Munich 24
Johannesburg 22
Stockholm 22
Orange 20
Pune 20
Jinan 19
Phoenix 19
Sydney 19
Warsaw 19
Zhengzhou 19
Baghdad 18
Denver 17
Montreal 17
Rio de Janeiro 17
Tokyo 17
Auburn Hills 16
Da Nang 16
Genoa 16
Hangzhou 16
Ningbo 16
Catania 15
Columbus 15
Mexico City 15
Brescia 14
Chennai 14
Haiphong 14
Manchester 14
Mumbai 14
Falls Church 13
Totale 114.716
Nome #
Child and Adolescent Behavior Inventory (CABI): Standardization for age 6-17 years and first clinical application 2.107
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.884
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder 1.855
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate 1.704
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.644
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder 1.621
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.605
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.567
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.518
Cognitive training for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials 1.506
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) 1.489
Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents 1.468
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives 1.467
The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations 1.421
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe 1.408
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.368
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles 1.317
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 1.308
Corrigendum: Child and adolescent behavior inventory (CABI): A new instrument for epidemiological studies and pre-clinical evaluation 1.299
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.268
ADHD and hyperkinetic disorder 1.253
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group 1.250
Re-thinking treatment targets in child and adolescent psychiatry 1.214
null 1.154
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.148
CRS-R. Conners’ Rating Scales. Revised. Manuale 1.093
Psychosocial risk factors for suicidality in children and adolescents 1.091
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 1.061
null 1.045
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 1.029
null 980
A neurodevelopment approach for a transitional model of early onset schizophrenia 976
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies 959
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 937
Systematic Review and Meta-analysis: Screening Tools for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 866
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 865
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: A systematic review of head-to-head studies[ BMC Psychiatry. (2013)13, 237] 823
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 818
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 812
Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA Study 804
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 793
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial 773
null 754
null 750
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 746
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 732
Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply 732
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 727
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG) 706
null 699
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study 690
null 689
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 682
null 675
null 665
null 658
The poor outcome of conduct disorders: a need for innovative, more effective therapeutic interventions 633
null 632
Increased Response-Time Variability Across Different Cognitive Tasks in Children With ADHD 632
Eziologia 625
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 609
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial 604
null 603
null 595
null 588
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 582
null 581
null 581
A crucial role for basic emotion awareness in the development of emotion regulation? 580
Association of Risk of Suicide Attempts With Methylphenidate Treatment 576
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 571
null 568
null 564
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 551
null 549
Management and treatment of attention-deficit/hyperactivity disorder 543
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and comorbid conditions 539
I Disturbi depressivi in età evolutiva 538
null 536
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents 535
The MTA at 8 522
Non-pharmacological interventions for Attention-Deficit/Hyperactivity Disorder: Systematic review and meta-analyses of randomised controlled trials of dietary and psychological treatments 522
null 519
null 517
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design 517
null 506
SRS Social Responsiveness Scale di John N. Constantino e Christian P. Grube 505
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 501
European clinical guidelines for hyperkinetic disorder - first upgrade 501
null 501
null 501
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review 498
null 497
null 491
null 477
null 467
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 464
Face and emotion recognition in children with ADHD and autism spectrum disorders: effects of methylphenidate 446
null 444
EffEtti sulla crescita della terapia a lungo termine con metilfenidato in bambini e adolescenti con disturbo da deficit di attenzione e iperattività (ADHD) 441
Totale 86.225
Categoria #
all - tutte 187.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.199


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.717 573 518 324 892 763 432 371 602 813 872 740 817
2022/202314.499 1.096 1.876 1.615 1.101 1.067 1.151 670 1.949 962 856 1.497 659
2023/202416.961 829 681 632 1.058 1.953 2.626 2.791 1.014 844 1.224 1.784 1.525
2024/202533.367 5.755 8.871 5.369 4.342 2.223 1.915 1.670 232 420 1.380 581 609
2025/202610.186 678 333 998 776 851 908 1.366 817 741 1.378 805 535
2026/202729 29 0 0 0 0 0 0 0 0 0 0 0
Totale 124.470